Table of Contents
International Scholarly Research Notices
Volume 2015, Article ID 284042, 9 pages
http://dx.doi.org/10.1155/2015/284042
Research Article

Oral Metformin Treatment Counteracts Adipoinsular Axis Dysfunction in Hypothalamic Obese Rats

1Neuroendocrine Unit, IMBICE (CONICET-CICPBA), La Plata Medical School, 1900 La Plata, Argentina
2CENEXA (UNLP-CONICET La Plata), La Plata Medical School, 1900 La Plata, Argentina

Received 29 December 2014; Revised 16 March 2015; Accepted 17 March 2015

Academic Editor: Karen M. von Deneen

Copyright © 2015 Daniel Castrogiovanni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Olney and L. G. Sharpe, “Brain lesions in an infant rhesus monkey treated with monosodium glutamate,” Science, vol. 166, no. 3903, pp. 386–388, 1969. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Burde, B. Schainker, and J. Kayes, “Acute effect of oral and subcutaneous administration of monosodium glutamate on the arcuate nucleus of the hypothalamus in mice and rats,” Nature, vol. 233, no. 5314, pp. 58–60, 1971. View at Publisher · View at Google Scholar · View at Scopus
  3. T. W. Redding, A. V. Schally, A. Arimura, and I. Wakabayashi, “Effect of monosodium glutamate on some endocrine functions,” Neuroendocrinology, vol. 8, no. 3, pp. 245–255, 1971. View at Publisher · View at Google Scholar · View at Scopus
  4. C. B. Nemeroff, L. D. Grant, G. Bissette, G. N. Ervin, L. E. Harrell, and A. J. Prange Jr., “Growth, endocrinological and behavioral deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage,” Psychoneuroendocrinology, vol. 2, no. 2, pp. 179–196, 1977. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Holzwarth-McBride, J. R. Sladek Jr., and K. M. Knigge, “Monosodium glutamate induced lesions of the arcuate nucleus. II. Fluorescence histochemistry of catecholamines,” Anatomical Record, vol. 186, no. 2, pp. 197–205, 1976. View at Publisher · View at Google Scholar · View at Scopus
  6. D. T. Krieger, A. S. Liotta, G. Nicholsen, and J. S. Kizer, “Brain ACTH and endorphin reduced in rats with monosodium glutamate-induced arcuate nuclear lesions,” Nature, vol. 278, no. 5704, pp. 562–563, 1979. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Pelletier, “Ultrastructural localization of neuropeptide Y in the hypothalamus,” Annals of the New York Academy of Sciences, vol. 611, pp. 232–246, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Billington, J. E. Briggs, S. Harker, M. Grace, and A. S. Levine, “Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism,” American Journal of Physiology, vol. 266, no. 6, pp. R1765–R1770, 1994. View at Google Scholar · View at Scopus
  9. U. H. Malabu, A. Kilpatrick, M. Ware, R. G. Vernon, and G. Williams, “Increased neuropeptide Y concentrations in specific hypothalamic regions of lactating rats: possible relationship ot hyperphagia and adaptive changes in energy balance,” Peptides, vol. 15, no. 1, pp. 83–87, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Miller and G. Dawson, “Neuoreceptors: an overview,” in Receptor for Neurotransmitters and Peptide Hormones, G. Pepeu, M. J. Kuhar, and S. J. Enna, Eds., pp. 11–19, Raven Press, New York, NY, USA, 1979. View at Google Scholar
  11. L. V. DePaolo and A. Negro-Vilar, “Neonatal monosodium glutamate treatment alters the response of median eminence luteinizing hormone-releasing hormone nerve terminals to potassium and prostaglandin E2,” Endocrinology, vol. 110, no. 3, pp. 835–841, 1982. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Spinedi, C. Johnston, and A. Negro-Vilar, “Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation,” Endocrinology, vol. 115, no. 1, pp. 267–272, 1984. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Perelló, R. C. Gaillard, A. Chisari, and E. Spinedi, “Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin,” Neuroendocrinology, vol. 78, no. 3, pp. 176–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. B. Nemeroff, R. J. Konkol, G. Bissette et al., “Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation,” Endocrinology, vol. 101, no. 2, pp. 613–622, 1977. View at Publisher · View at Google Scholar · View at Scopus
  15. G. H. Greeley Jr., G. F. Nicholson, C. B. Nemeroff, W. W. Youngblood, and J. S. Kizer, “Direct evidence that the arcuate nucleus-median eminence tuberoinfundibular system is not of primary importance in the feedback regulation of luteinizing hormone and follicle-stimulating hormone secretion in the castrated rat,” Endocrinology, vol. 103, no. 1, pp. 170–175, 1978. View at Publisher · View at Google Scholar · View at Scopus
  16. T. M. Badger, W. J. Millard, J. B. Martin, P. M. Rosenblum, and S. E. Levenson, “Hypothalamic-pituitary function in adult rats treated neonatally with monosodium glutamate,” Endocrinology, vol. 111, no. 6, pp. 2031–2038, 1982. View at Publisher · View at Google Scholar · View at Scopus
  17. E. L. Bliss, J. Ailion, and J. Zwanziger, “Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress,” Journal of Pharmacology and Experimental Therapeutics, vol. 164, no. 1, pp. 122–134, 1968. View at Google Scholar · View at Scopus
  18. M. Palkovits, M. Brownstein, J. S. Kizer, J. M. Saavedra, and I. J. Kopin, “Effect of stress on serotonin concentration and tryptophan hydroxylase activity of brain nuclei,” Neuroendocrinology, vol. 22, no. 4, pp. 298–304, 1976. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Dinarello, “Interleukin-1 and the pathogenesis of the acute-phase response,” The New England Journal of Medicine, vol. 311, no. 22, pp. 1413–1418, 1984. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Krueger, J. Walter, C. A. Dinarello, S. M. Wolff, and L. Chedid, “Sleep-promoting effects of endogenous pyrogen (interleukin-1),” The American Journal of Physiology, vol. 246, no. 6, part 2, pp. R994–R999, 1984. View at Google Scholar · View at Scopus
  21. E. Spinedi, R. Hadid, T. Daneva, and R. C. Gaillard, “Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action,” Neuroendocrinology, vol. 56, no. 1, pp. 46–53, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra, “Interacting appetite-regulating pathways in the hypothalamic regulation of body weight,” Endocrine Reviews, vol. 20, no. 1, pp. 68–100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Morris, C. F. Tortelli, A. Filippis, and J. Proietto, “Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat,” Regulatory Peptides, vol. 75-76, pp. 441–447, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Moreno, M. Perelló, G. Camihort et al., “Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats,” International Journal of Obesity, vol. 30, no. 1, pp. 73–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Dawson, M. A. Pelleymounter, W. J. Millard, S. Liu, and B. Eppler, “Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage,” American Journal of Physiology, vol. 273, no. 1, pp. E202–E206, 1997. View at Google Scholar · View at Scopus
  26. M. Perelló, G. Moreno, G. Camihort et al., “Nature of changes in adrenocortical function in chronic hyperleptinemic female rats,” Endocrine, vol. 24, no. 2, pp. 167–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Castrogiovanni, R. C. Gaillard, A. Giovambattista, and E. Spinedi, “Neuroendocrine, metabolic, and immune functions during the acute phase response of inflammatory stress in monosodium L-glutamate-damaged, hyperadipose male rat,” Neuroendocrinology, vol. 88, no. 3, pp. 227–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Alzamendi, H. Del Zotto, D. Castrogiovanni, J. Romero, A. Giovambattista, and E. Spinedi, “Oral metformin treatment prevents enhanced insulin demand and placental dysfunction in the pregnant rat fed a fructose-rich diet,” ISRN Endocrinology, vol. 2012, Article ID 757913, 8 pages, 2012. View at Publisher · View at Google Scholar
  29. T. Chautard, E. Spinedi, M.-J. Voirol, F. P. Pralong, and R. C. Gaillard, “Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration,” Neuroendocrinology, vol. 69, no. 5, pp. 360–369, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Giovambattista, R. C. Gaillard, and E. Spinedi, “Ghrelin gene-related peptides modulate rat white adiposity,” Vitamins and Hormones, vol. 77, pp. 171–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Zar, Biostatistical Analysis, Prentice-Hall, Englewood Cliffs, NJ, USA, 1974.
  32. N. S. Lobato, F. P. Filgueira, G. N. Hagihara et al., “Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats,” Life Sciences, vol. 90, no. 5-6, pp. 228–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. K. Burlá, N. S. Lobato, Z. B. Fortes, W. Oigman, and M. F. Neves, “Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats,” International Journal of Cardiology, vol. 165, no. 3, pp. 483–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. C. B. Ferreira, M. L. Cesaretti, M. Ginoza, and O. Kohlmann Jr., “Metformin effects upon blood pressure and glucose metabolism of monossodium glutamate induced-obese spontaneously hypertensive rats,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 4, pp. 409–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Baret, J. Peyronnet, D. Grassi-Kassisse, Y. Dalmaz, N. Wiernsperger, and A. Géloën, “Increased intraabdominal adipose tissue mass in fructose fed rats: correction by metformin,” Experimental and Clinical Endocrinology & Diabetes, vol. 110, no. 6, pp. 298–303, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Nakagawa, K. Ukai, T. Ohyama, Y. Gomita, and H. Okamura, “Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines,” Experimental Animals, vol. 49, no. 4, pp. 239–249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. F. S. M. Leigh, L. N. Kaufman, and J. B. Young, “Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats,” International Journal of Obesity, vol. 16, no. 8, pp. 597–604, 1992. View at Google Scholar · View at Scopus
  38. N. Apaijai, H. Pintana, S. C. Chattipakorn, and N. Chattipakorn, “Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet,” Endocrinology, vol. 153, no. 8, pp. 3878–3885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Alzamendi, A. Giovambattista, M. E. García, O. R. Rebolledo, J. J. Gagliardino, and E. Spinedi, “Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction,” PPAR Research, vol. 2012, Article ID 259093, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. T. R. Nardelli, R. A. Ribeiro, S. L. Balbo et al., “Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats,” Amino Acids, vol. 41, no. 4, pp. 901–908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. L. Bonfleur, R. A. Ribeiro, A. Pavanello et al., “Duodenal-jejunal bypass restores insulin action and beta-cell function in hypothalamic-obese rats,” Obesity Surgery, 2014. View at Publisher · View at Google Scholar
  42. M. Dolnikoff, A. Martín-Hidalgo, U. F. Machado, F. B. Lima, and E. Herrera, “Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats,” International Journal of Obesity & Related Metabolic Disorders, vol. 25, no. 3, pp. 426–433, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Maiter, L. E. Underwood, J. B. Martin, and J. I. Koenig, “Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats,” Endocrinology, vol. 128, no. 2, pp. 1100–1106, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Munir and J. Newell-Price, “Management of diabetes mellitus in Cushing's syndrome,” Neuroendocrinology, vol. 92, no. 1, pp. 82–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Tessari and A. Tiengo, “Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver,” Acta Diabetologica, vol. 45, no. 3, pp. 143–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Srividhya, M. K. Ravichandran, and C. V. Anuradha, “Metformin attenuates blood lipid peroxidation and potentiates antioxidant defense in high fructose-fed rats,” Journal of Biochemistry, Molecular Biology and Biophysics, vol. 6, no. 6, pp. 379–385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Ren, J. He, H. Jiang et al., “Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-α or isoproterenol,” Journal of Molecular Endocrinology, vol. 37, no. 1, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. N. F. Wiernsperger and C. J. Bailey, “The antihyperglycaemic effect of metformin. Therapeutic and cellular mechanisms,” Drugs, vol. 58, no. 1, pp. 31–39, 1999. View at Google Scholar · View at Scopus
  49. J. H. Exton, “Regulation of gluconeogenesis by glucocorticoids,” Monographs in Endocrinology, vol. 12, pp. 535–546, 1979. View at Publisher · View at Google Scholar · View at Scopus
  50. M. R. Yelich, H. S. Havdala, and J. P. Filkins, “Dexamethasone alters glucose, lactate, and insulin dyshomeostasis during endotoxicosis in the rat,” Circulatory Shock, vol. 22, no. 2, pp. 155–171, 1987. View at Google Scholar · View at Scopus
  51. E. Spinedi, M. Giacomini, M.-C. Jacquier, and R. C. Gaillard, “Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action,” Neuroendocrinology, vol. 53, no. 2, pp. 160–170, 1991. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Balbo, S. Grassiolli, R. Ribeiro et al., “Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat,” Endocrine, vol. 31, no. 2, pp. 142–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. H. T. Bergen, T. M. Mizuno, J. Taylor, and C. V. Mobbs, “Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin,” Endocrinology, vol. 139, no. 11, pp. 4483–4488, 1998. View at Publisher · View at Google Scholar · View at Scopus